Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing
The (Un)holy Grail: With the Divestment of Grail by Illumina, What’s in Store for the Future of DNA Sequencing and Liquid Bio?